Suchergebnisse - "Davis, Hugh"

PubPharm (24)

1

Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-Severely Active Ulcerative Colitis : Results from Phase 2/3 PURSUIT Induction and Maintenance Studies

enthalten in: Journal of Crohn's & colitis | 2017

von Adedokun, O. | Xu, Z. | Marano, C. | +9

2

First-in-human study to assess guselkumab (anti-IL-23 mAb) pharmacokinetics/safety in healthy subjects and patients with moderate-to-severe psoriasis

enthalten in: European journal of clinical pharmacology | 2016

von Zhuang, Y. | Calderon, C. | Marciniak, S. | +7

3

Pharmacokinetic bridging approach for developing biologics-delivery devices : a case study with a golimumab autoinjector

enthalten in: Clinical therapeutics | 2015

von Xu, Z. | Marciniak, S. | Frederick, B. | +4

4

Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis

enthalten in: Gastroenterology | 2014

von Adedokun, O. | Sandborn, W. | Feagan, B. | +8

5

A phase 1, randomized study to assess the pharmacokinetic comparability of siltuximab derived from two different cell lines in healthy subjects

enthalten in: Clinical pharmacology in drug development | 2014

von Xu, C. | Han, C. | Marini, J. | +9

6

Pharmacokinetics of infliximab in children with moderate-to-severe ulcerative colitis : results from a randomized, multicenter, open-label, phase 3 study

enthalten in: Inflammatory bowel diseases | 2013

von Adedokun, O. | Xu, Z. | Padgett, L. | +8

7

Pharmacokinetics and safety of golimumab in healthy Chinese subjects following a single subcutaneous administration in a randomized phase I trial

enthalten in: Clinical drug investigation | 2013

von Zhuang, Y. | Lyn, S. | Lv, Y. | +8

8

Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study

enthalten in: British journal of clinical pharmacology | 2013

von van Hartingsveldt, B. | Nnane, I. | Bouman-Thio, E. | +4

9

Comparison of the pharmacokinetics of subcutaneous ustekinumab between Chinese and non-Chinese healthy male subjects across two Phase 1 studies

enthalten in: Clinical drug investigation | 2013

von Zhu, Y. | Wang, Q. | Frederick, B. | +6

10

Pharmacokinetics and safety of sirukumab following a single subcutaneous administration to healthy Japanese and Caucasian subjects

enthalten in: International journal of clinical pharmacology and therapeutics | 2013

von Zhuang, Y. | Xu, Z. | de Vries, D. | +10